Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer

J Clin Invest. 2023 Jun 1;133(11):e172059. doi: 10.1172/JCI172059.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • B7-H1 Antigen
  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Immunotherapy
  • Neoadjuvant Therapy
  • Papillomavirus Infections*
  • Transforming Growth Factor beta

Substances

  • B7-H1 Antigen
  • Transforming Growth Factor beta